BioSpace News Archive

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has been working with Swiss-based Santersus AG, a private company that has an abstract released today at the International Society for Apheresis meeting (e-ISFA),

Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced today that its Chief Executive Officer Saiid Zarrabian will participate in the Benzinga Biotech Small Cap Conference to be held March 24-25, 2021.

Cognito Therapeutics, a clinical-stage company developing a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders, announced today that it will advance its lead product which has received FDA Breakthrough Device Designation, into pivotal studies in the second half of this year, based on results from two clinical studies announced at the Alzheimer’s Disease Parkinson’s Disease Conference (AD/PD) 2021.

Lotus Pharmaceuticals, Inc (Pink Sheets: LTUS) President Georgene Rivers announced today that Lotus Pharmaceuticals, Inc. has become current with OTC MARKETS

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need, presented data from its Phase 1 and 2 programs of tildacerfont in adults with classic congenital adrenal hyperplasia (CAH) from the Endocrine Society’s 2021 Annual Meeting, taking place virtually March 20 – 23, 2021

Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, reports financial results for the year ended December 31, 2020 and provides updates on its antiviral pipeline and business activities.

Xcelerate, Inc. (OTC: XCRT), formerly known as Union Dental Holdings Inc., announced today it has been issued a new ticker symbol due to the Company’s recent name change.

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing the appointment of Jennifer Main as chief operating officer (COO) and chief financial officer (CFO)

More than 40 preclinical studies have found that Lixte’s lead drug candidate LB-100 increases the anti-tumor activity of chemotherapy, radiotherapy and immunotherapy without increasing toxicity

EMulate Therapeutics Inc., a clinical-stage therapeutic device company, is featured in a Healthcare Tech Outlook article, titled “Ushering in a New Era in Non-Invasive Cancer Therapy,” written by Jessica Stanley.